Immunovia AB (IMMNOV) NPV

Sell:0.45 SEKBuy:0.45 SEK0.00 SEK (0.67%)

Prices delayed by at least 15 minutes
Sell:0.45 SEK
Buy:0.45 SEK
Change:0.00 SEK (0.67%)
Deal now
Prices delayed by at least 15 minutes
Sell:0.45 SEK
Buy:0.45 SEK
Change:0.00 SEK (0.67%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Immunovia AB (publ) is a Sweden-based diagnostic company that is developing and commercializing blood tests for the early detection of cancer and autoimmune diseases based on Immunovia’s test platform called IMMray. Tests are based on antibody biomarker microarray analysis using machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a disease biomarker signature. Immunovia Dx Laboratories locations in USA and Sweden provides laboratory testing services in two accredited reference laboratories.

Key people

Jeff Borcherding
President, Chief Executive Officer
Karin Almqvist Liwendahl
Chief Financial Officer
Karl Stone
Chief Operating Officer
Peter Hongaard Andersen
Independent Chairman of the Board
Valerie Bogdan-powers
Independent Director
Melissa Farina
Independent Director
Hans Johansson
Independent Director
Michael Loefman
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Sweden
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    SE0006091997
  • Market cap
    SEK 117.47m
  • Employees
    9
  • Shares in issue
    169.71m
  • Exchange
    Stockholm Stock Exchange
  • Index
    SX All Share PI Market Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.